The Latest in Melanoma

Cancer prevention field riding high into the new year

January 11, 2016

Melanoma

FDA approves pembrolizumab as first-line advanced melanoma therapy

December 23, 2015

Melanoma

FDA proposes ban on indoor tanning for minors

December 18, 2015

FDA approves treatment for chemotherapy ODs, life-threatening toxicities

December 11, 2015

EADV: Focus on non-UV triggers of melanoma

December 11, 2015

Melanoma

EADV: Fresh insights into Gorlin syndrome

December 11, 2015

Nivolumab approved as first-line, single agent for advanced melanoma

November 24, 2015

Melanoma

Dermatologists’ management of melanoma varies

November 21, 2015

Immune-related events with checkpoint inhibitors are manageable

November 18, 2015

Melanoma

Successive gene mutations causing melanoma progression identified

November 11, 2015

Melanoma

Cobimetinib approved as add-on to vemurafenib for advanced melanoma

November 10, 2015

Melanoma

Lenalidomide plus rituximab achieves 87% response rate

November 4, 2015

Melanoma

Higher risk of basal cell carcinoma linked to menopausal hormone therapy

November 2, 2015

Melanoma

ASTRO: Combined radioimmunotherapy proves promising in metastatic melanoma

November 1, 2015

Melanoma

Ipilimumab approved as adjuvant treatment for resected metastatic melanoma

October 29, 2015

Melanoma